Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Bone Joint Surg Am. 2008 Feb;90 Suppl 1:43-7. doi: 10.2106/JBJS.G.01090.

Critical issues in translational and clinical research for the study of new technologies to enhance bone repair.

Author information

  • 1Department of Research, Schulthess Klinik, Lengghalde 2, Zurich 8008, Switzerland. joerg.goldhahn@kws.ch

Abstract

Osteoporosis increases fracture risk, especially in metaphyseal bone. Fractures seriously impair function and quality of life and incur large direct and indirect costs. Although the prevention of fractures is certainly the option, a fast and uneventful healing process is optimal when fractures do occur. Many new therapeutic strategies have been developed to accelerate fracture-healing or to diminish the complication rate during the course of fracture-healing. However, widely accepted guidelines are needed to demonstrate the positive or negative interactions of bioactive substances, drugs, and other agents that are being used to promote fracture-healing. For each study design, the primary study goal should be indicated. Outcome variables should include both objective and subjective parameters. The guidelines should be harmonized between European and American regulatory authorities to ensure comparability of results of studies and to foster global harmonization of regulatory requirements.

PMID:
18292356
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk